| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1977 |
| Trial ID | NCT03676504 |
| Disease | Follicular Lymphoma | Mantle Cell Lymphoma | Childhood Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 3rd |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR |
| Year | 2018 |
| Country | Germany |
| Company sponsor | University Hospital Heidelberg |
| Other ID(s) | HD-CAR-1 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||
|
|||||||||||||